John Kovach - President and CEO, Director at Lixte Biotechnology Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
LIXT, LIXTW on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by John Kovach since 12/26/2023

Holdings reported by John Kovach for Lixte Biotechnology Holdings, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Options 200K Nov 6, 2022 Direct Common
Warrants to Purchase Common Stock 21.1K Nov 6, 2022 By John S. Kovach Trust Common 21.1K

Transactions reported by John Kovach for Lixte Biotechnology Holdings, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.